跳至主要内容
临床试验/NCT03403179
NCT03403179
已完成
不适用

A Pilot Study of Functional Remediation for Bipolar Disorder: Feasibility and Preliminary Efficacy

University of Michigan1 个研究点 分布在 1 个国家目标入组 30 人2017年11月17日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Bipolar Disorder
发起方
University of Michigan
入组人数
30
试验地点
1
主要终点
Feasibility
状态
已完成
最后更新
7年前

概览

简要总结

Bipolar Disorder is a major mood disorder with periodic mood episodes that may be very distressing, both to the individual and to others. When ill, the person is at particular risk for disruptions to social and occupational functioning, physical health, and even premature death. When not in an episode, individuals with BD may still be feeling well but have ongoing neurobiological processes, as well as the psychological sequelae from illness episodes, that can lead to subtle neurocognitive impairment that impedes overall functioning. This study is a test of an existing, published intervention that ameliorates deficits in functioning in euthymic bipolar individuals.

注册库
clinicaltrials.gov
开始日期
2017年11月17日
结束日期
2018年12月20日
最后更新
7年前
研究类型
Interventional
研究设计
Single Group
性别
All

研究者

责任方
Principal Investigator
主要研究者

Sagar Parikh

Professor of Psychiatry

University of Michigan

入排标准

入选标准

  • diagnosis of bipolar I or II disorder (BD), as determined by a structured diagnostic interview
  • at least three months of clinical remission (euthymia or minimal symptoms), based on the phone screen assessing mood episodes in the prior three months
  • score greater than 11 on a measure of everyday functioning (FAST; described in measures section) indicating at least mild impairment
  • use of a standard bipolar mood-stabilizing medication at the same, adequate dose (according to CANMAT treatment guidelines) for at least 3 months prior to screening, with ability to continue that dose during the study.

排除标准

  • history of neurological illness or injury (e.g., stroke, brain tumor)
  • documented intellectual disability
  • inability to provide written informed consent
  • substance dependence within last 3 months or substance abuse in last 30 days
  • inability to complete the six-month intervention
  • received ECT in the past 12 months

结局指标

主要结局

Feasibility

时间窗: 30 weeks

Feasibility will be determined by a composite of ability to recruit and deliver the treatment intervention to both cohorts of participants, with adequate delivery of the intervention as measured by completion of the manual's objectives.

Acceptability (Subject Satisfaction)

时间窗: 30 weeks

Acceptability of the intervention will be measured by use of the Satisfaction with Therapy and Therapist Scale.

Acceptability (Subject completion)

时间窗: 30 weeks

Measured by percentage of subjects who complete the intervention.

次要结局

  • Functional Impact(30 weeks)

研究点 (1)

Loading locations...

相似试验